[Molecular and other ancillary tests proposed by The Bethesda system for reporting thyroid cytopathology 2023]. / Les tests moléculaires et autres techniques ancillaires en cytologie thyroïdienne selon Bethesda 2023.
Ann Pathol
; 44(1): 36-46, 2024 Feb.
Article
in Fr
| MEDLINE
| ID: mdl-37953129
Key words
Afirma; Atypia of undeterminated significance (AUS); Atypies de signification indéterminée (ASI); Cytoponction à l'aiguille fine (FNA); Fine needle aspiration (FNA); Follicular neoplasm (NF); New generation sequencing (NGS); Néoplasme folliculaire (NF); Séquençage de nouvelle génération (NGS); Test moléculaire « maison ¼; ThyGeNEXT; ThyraMIR; Thyroseq; « In-house ¼ Molecular testing
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Thyroid Nodule
/
Adenocarcinoma, Follicular
Limits:
Humans
Language:
Fr
Journal:
Ann Pathol
Year:
2024
Document type:
Article
Country of publication:
France